TB-500 requires less frequent dosing due to its longer half-life but costs 40% to 60% more than BPC-157
danuglipron oral GLP-1 discontinued 2024 Key Peptide Products: Somavert (pegvisomant GH receptor antagonist), Genotropin (somatropin growth hormone peptide), BNT116/mRNA oncology vaccines, historical insulin franchise, Lupron (leuprolide US rights via Abbvie partnership) Therapeutic Segments: Oncology (Ibrance, Xtandi partnership, Padcev, Lorbrena)
1987 Mar 23;40(12):1201-6
In wound healing studies, GHK-Cu injected into one area of the body (such as thigh muscles) improved healing at completely different locations (such as the ears)
Ready to See the Change
Cardiovascular disease: Monitor blood pressure due to potential NO interaction Autoimmune disorders: Consider immune modulation risks with chronic peptide use Cancer history: Use with caution due to angiogenesis stimulation Always consult a healthcare provider if you have any preexisting medical condition or take prescription medications
